{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} Rapid Sequence Intubation Medication Therapies: A Review in Light of Recent Drug Shortages

Purpose of Activity

The purpose of this learning activity is to provide information about medication therapies used during rapid sequence intubation (RSI).

Learning Objectives/Outcomes

After completing this continuing education activity you will be able to:

  1. Associate RSI medications with their uses, side effects, adverse effects, and dosing.
  2. Discuss patient care during and in the event of adverse effects of RSI.
Price: $24.95


  • ANCC 2.8 CH / 2.8 APH
  • DC - BON 2.8 CH
  • DC - BON 2.8 CH
  • FL - BON 2.5 CH
  • FL - BON 2.5 CH

Lippincott Williams & Wilkins is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.
This activity is also provider approved by the California Board of Registered Nursing, Provider Number CEP 11749. Lippincott Williams & Wilkins is also an approved provider of continuing nursing education by the District of Columbia and Florida #50-1223. Your certificate is valid in all states.
The ANCC's accreditation status of Lippincott Williams & Wilkins Department of Continuing Education refers only to its continuing nursing educational activities and does not imply Commission on Accreditation approval or endorsement of any commercial product.

Awarded Advanced Pharmacology Hours.

Test Code: AENJ0113
Published: January/March 2013
Expires: 3/6/2020
Passing Score: 13/18 (72%)
Authors: Molly A. Mason PharmD, BCPS, Kyle A. Weant PharmD, BCPS, Stephanie N. Baker PharmD, BCPSr
Specialties: Critical Care, Emergency